Pharmacodynamic effect of cilostazol versus clopidogrel in stented patients during proton pump inhibitor co-administration: the ACCEL-PARAZOL study
Phase of Trial: Phase IV
Latest Information Update: 17 Oct 2013
Price : $35 *
At a glance
- Drugs Cilostazol (Primary) ; Aspirin; Clopidogrel; Lansoprazole
- Indications Cardiovascular disorders; Gastrointestinal disorders
- Focus Pharmacodynamics
- Acronyms ACCEL-PARAZOL
- 17 Oct 2013 New trial record
- 03 Sep 2013 Primary endpoint 'Platelet-aggregation' has not been met.
- 03 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.